356 related articles for article (PubMed ID: 15932940)
1. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.
Palhan VB; Chen S; Peng GH; Tjernberg A; Gamper AM; Fan Y; Chait BT; La Spada AR; Roeder RG
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8472-7. PubMed ID: 15932940
[TBL] [Abstract][Full Text] [Related]
2. Both normal and polyglutamine- expanded ataxin-7 are components of TFTC-type GCN5 histone acetyltransferase- containing complexes.
Helmlinger D; Hardy S; Eberlin A; Devys D; Tora L
Biochem Soc Symp; 2006; (73):155-63. PubMed ID: 16626296
[TBL] [Abstract][Full Text] [Related]
3. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.
Chen S; Peng GH; Wang X; Smith AC; Grote SK; Sopher BL; La Spada AR
Hum Mol Genet; 2004 Jan; 13(1):53-67. PubMed ID: 14613968
[TBL] [Abstract][Full Text] [Related]
4. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes.
Helmlinger D; Hardy S; Sasorith S; Klein F; Robert F; Weber C; Miguet L; Potier N; Van-Dorsselaer A; Wurtz JM; Mandel JL; Tora L; Devys D
Hum Mol Genet; 2004 Jun; 13(12):1257-65. PubMed ID: 15115762
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
La Spada AR; Fu YH; Sopher BL; Libby RT; Wang X; Li LY; Einum DD; Huang J; Possin DE; Smith AC; Martinez RA; Koszdin KL; Treuting PM; Ware CB; Hurley JB; Ptácek LJ; Chen S
Neuron; 2001 Sep; 31(6):913-27. PubMed ID: 11580893
[TBL] [Abstract][Full Text] [Related]
6. Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction.
Helmlinger D; Hardy S; Abou-Sleymane G; Eberlin A; Bowman AB; Gansmüller A; Picaud S; Zoghbi HY; Trottier Y; Tora L; Devys D
PLoS Biol; 2006 Mar; 4(3):e67. PubMed ID: 16494529
[TBL] [Abstract][Full Text] [Related]
7. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity.
McMahon SJ; Pray-Grant MG; Schieltz D; Yates JR; Grant PA
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8478-82. PubMed ID: 15932941
[TBL] [Abstract][Full Text] [Related]
8. Crx activates opsin transcription by recruiting HAT-containing co-activators and promoting histone acetylation.
Peng GH; Chen S
Hum Mol Genet; 2007 Oct; 16(20):2433-52. PubMed ID: 17656371
[TBL] [Abstract][Full Text] [Related]
9. Direct inhibition of Gcn5 protein catalytic activity by polyglutamine-expanded ataxin-7.
Burke TL; Miller JL; Grant PA
J Biol Chem; 2013 Nov; 288(47):34266-34275. PubMed ID: 24129567
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase-3 interacts with ataxin-7 and is altered in a spinocerebellar ataxia type 7 mouse model.
Duncan CE; An MC; Papanikolaou T; Rugani C; Vitelli C; Ellerby LM
Mol Neurodegener; 2013 Oct; 8():42. PubMed ID: 24160175
[TBL] [Abstract][Full Text] [Related]
11. A role for both wild-type and expanded ataxin-7 in transcriptional regulation.
Ström AL; Forsgren L; Holmberg M
Neurobiol Dis; 2005 Dec; 20(3):646-55. PubMed ID: 15936949
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype.
Aleman TS; Cideciyan AV; Volpe NJ; Stevanin G; Brice A; Jacobson SG
Exp Eye Res; 2002 Jun; 74(6):737-45. PubMed ID: 12126946
[TBL] [Abstract][Full Text] [Related]
13. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
[TBL] [Abstract][Full Text] [Related]
14. MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits.
Zhang N; Ichikawa W; Faiola F; Lo SY; Liu X; Martinez E
Biochim Biophys Acta; 2014 May; 1839(5):395-405. PubMed ID: 24705139
[TBL] [Abstract][Full Text] [Related]
15. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.
Mookerjee S; Papanikolaou T; Guyenet SJ; Sampath V; Lin A; Vitelli C; DeGiacomo F; Sopher BL; Chen SF; La Spada AR; Ellerby LM
J Neurosci; 2009 Dec; 29(48):15134-44. PubMed ID: 19955365
[TBL] [Abstract][Full Text] [Related]
17. RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.
Ramachandran PS; Bhattarai S; Singh P; Boudreau RL; Thompson S; Laspada AR; Drack AV; Davidson BL
PLoS One; 2014; 9(4):e95362. PubMed ID: 24759684
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional alterations and chromatin remodeling in polyglutamine diseases.
Helmlinger D; Tora L; Devys D
Trends Genet; 2006 Oct; 22(10):562-70. PubMed ID: 16911843
[TBL] [Abstract][Full Text] [Related]
19. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.
Chen YC; Gatchel JR; Lewis RW; Mao CA; Grant PA; Zoghbi HY; Dent SY
Hum Mol Genet; 2012 Jan; 21(2):394-405. PubMed ID: 22002997
[TBL] [Abstract][Full Text] [Related]
20. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.
Yvert G; Lindenberg KS; Picaud S; Landwehrmeyer GB; Sahel JA; Mandel JL
Hum Mol Genet; 2000 Oct; 9(17):2491-506. PubMed ID: 11030754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
